Global Competent Cells Market is Expected to Reach US$ 2,365.5 Mn by 2025, Due to Surge in R&D for the Development of Newer Products
Analyst Speak:

“The Global Competent Cells Market is expected to reach US$ 2,365.5 Mn by 2025 owing to growth in R&D for the development of newer products”

The global competent cells market is valued around US$ 2.02 Bn over the forecast years. Competent cells are those cells which incorporate foreign DNA in their cells, if their cell walls are altered. It helps the foreign DNA to pass through them much easily. The global competent cells market is driven by increased research and development in the field of molecular biology and increased popularity of the genetically recombinant products. Competent cells has many uses such as to make multiple copies of DNAs for everyday cloning applications, to express large amounts of proteins and enzymes and in various studies related to DNA leakage. They are widely used in generation of cDNA libraries. However, there are certain factors which can hamper the growth of global competent cells market such as high cost of the competent cell kits, lack of skilled professionals and market consolidation.

Global competent cells market is segmented on the basis of type, application, end user, and region.

Request Sample Report:
https://www.precisionbusinessinsights.com/request-sample?product_id=18718

Pharmaceutical & Biotechnological Companies Dominate the Global Competent Cells Market

Based on the end user class, global competent cells market is segmented into pharmaceutical & biotechnological companies, CROs, and academic & research institutes. Pharmaceutical & biotechnological companies tend to dominate the global competent cells market due to rising investment in the research for development of recombinant and proteomics based products. For instance, , in July 2017, Intact has partnered with Geneva Biotech to offer North American customers competent cells containing Geneva Biotech’s viral genomes.
North America and Europe Leads the Global Competent Cells Market

PBI’s global competent cells market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to regional analysis, North America & Europe competent cells market accounted for larger revenue share through 2014-2018 and expected to dominate over 2019-2025 owing to their advancement in research and development sector, growing need for the genetically recombinant products and rise in innovation. However, Asia Pacific and Latin America competent cells market is expected to grow at a steady pace over the years due to increased research activity and emerging economies especially in countries like China and India. Increase of government’s interest in the research activities regarding the competent cells will surge the growth in Latin America and Africa competent cells market.

Launch of newer products, and strategic alliances are the key strategies adopted by market players

Global competent cells market further reveals that the key players increasingly adopting strategies such as launch of newer products, and long term alliance to improve market revenue share and gaining significant geographic presence across the region.
For instance, in September 2018, Geneva Biotech’s industry which is a leading producer of baculoviral genomes is available as competent cells in Europe, Asia, and North America.

Key player’s profiles in the report are Merck KGaA (Germany), Thermo Fisher Scientific, Inc. (U.S), Takara Bio (Japan), Promega Corporation (U.S.), New England Biolabs (U.S.), Agilent Technologies (U.S.), QIAGEN (Germany), Lucigen, Bioline (U.K.), Source BioScience (U.K.), GeneScript Corporation (U.S.), OriGene Technologies (U.S.), Geneva Biotech (Switzerland), Intact Genomics (US), Life Technologies (India) Pvt. Ltd., GCC Biotech (India), Genewiz (U.S.).

Precision Business Insights (PBI) in its report titled “Global Competent Cells Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period over 2019-2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

Detailed Segmentation

By Type
• Electrocompetent Cells
• Chemically Competent Cells

By Application
• Protein Expression
• Clonning
o Toxic/Unstable DNA Cloning
o High-throughput Cloning
o Subcloning & Routine Cloning
o Phage Display Library Construction
• Other Applications
o Lentiviral Vector Production
o Large Plasmid Transformation
o Mutagenesis
o Single-stranded DNA Production

By End User
• CROs
• Pharmaceutical & Biotechnological Companies
• Academic Research Institutes

Geography

o North America
• U.S
• Canada
o Europe
• Germany
• France
• U.K
• Italy
• Spain
• Russia
• Poland
• Rest of Europe
o Asia-Pacific
• Japan
• China
• India
• Australia & New Zealand
• ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
• South Korea
• Rest of Asia-Pacific
o Latin America
• Brazil
• Mexico
• Argentina
• Rest of Latin America
o Middle East and Africa (MEA)
• Gulf Cooperation Council (GCC) Countries
• Israel
• South Africa
• Rest of MEA


For More Information:
https://www.precisionbusinessinsights.com/market-reports/competent-cells-market/

Precision Business Insights is one of the leading market research and management consulting firm, run by a group of seasoned and highly dynamic market research professionals with a strong zeal to offer high-quality insights.

Contact Us:

Shreya Paul
Senior Business Development Executive
Email @ [email protected]
Call @ +1-866-598-1553
Precision Business Insights Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com